Skip to main content
. 2021 Sep 17;8:727481. doi: 10.3389/fmolb.2021.727481

FIGURE 3.

FIGURE 3

Relationship between METTL7B expression and clinical-pathological features. (A) Expression levels of METTL7B in gliomas with different WHO grades. (B) Expression levels of METTL7B in gliomas with different IDH status. (C) Expression levels of METTL7B with IDH/codel subtype in different WHO grades; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.